av/arca-biopharma--big.svg

COM:ARCABIO

Oruka Therapeutics

  • Stock

USD

Last Close

2.50

30/08 20:00

Market Cap

49.90M

Beta: -

Volume Today

290.85K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
gross profit
selling and marketing expenses
general and administrative expenses
4.01M
-
4.07M
1.40%
4.39M
7.96%
4.26M
2.89%
4.64M
8.70%
3.88M
16.33%
3.98M
2.63%
4.77M
19.92%
5.50M
15.27%
5.85M
6.25%
6.28M
7.46%
selling general and administrative expenses
4.01M
-
4.07M
1.40%
4.39M
7.96%
4.26M
2.89%
4.64M
8.70%
3.88M
16.33%
3.98M
2.63%
4.77M
19.92%
5.50M
15.27%
5.85M
6.25%
6.28M
7.46%
research and development expenses
2.93M
-
5.63M
92.11%
7.06M
25.56%
12.35M
74.83%
14.08M
13.99%
4.24M
69.88%
1.83M
56.76%
4.99M
172.34%
13.83M
177.08%
4.75M
65.67%
1.01M
78.67%
other expenses
-5K
-
cost and expenses
6.94M
-
9.69M
39.67%
11.46M
18.18%
16.61M
45.03%
18.71M
12.63%
8.12M
56.62%
5.81M
28.38%
9.77M
67.97%
19.34M
97.98%
10.60M
45.20%
7.30M
31.14%
operating expenses
6.94M
-
9.69M
39.67%
11.46M
18.18%
16.61M
45.03%
18.71M
12.63%
8.12M
56.62%
5.81M
28.38%
9.77M
67.97%
19.34M
97.98%
10.60M
45.20%
7.30M
31.14%
interest expense
4K
-
3K
25%
4K
33.33%
6K
-
8K
33.33%
7K
12.50%
9K
28.57%
675K
-
ebitda
-6.91M
-
-9.67M
40.02%
-11.42M
18.07%
-16.12M
41.17%
-18.55M
15.01%
-7.93M
57.22%
-5.55M
30.01%
-9.74M
75.36%
-19.32M
98.42%
-10.60M
45.16%
-7.30M
31.14%
operating income
-6.94M
-
-9.69M
39.67%
-11.46M
18.18%
-16.61M
45.03%
-18.71M
12.63%
-8.12M
56.62%
-5.81M
28.38%
-9.77M
67.97%
-19.34M
97.98%
-10.60M
45.20%
-7.30M
31.14%
depreciation and amortization
26K
-
12K
53.85%
19K
58.33%
320K
1,584.21%
356K
11.25%
22K
93.82%
261K
1,086.36%
28K
89.27%
13K
53.57%
114K
776.92%
total other income expenses net
1K
-
4K
300%
10K
150%
169K
1,590%
161K
4.73%
154K
4.35%
165K
7.14%
19K
88.48%
13K
31.58%
670K
5,053.85%
1.96M
192.09%
income before tax
-6.94M
-
-9.69M
39.63%
-11.45M
18.12%
-16.44M
43.68%
-18.55M
12.81%
-7.96M
57.07%
-5.65M
29.07%
-9.75M
72.54%
-19.32M
98.24%
-9.93M
48.63%
-5.34M
46.21%
income tax expense
5K
-
7K
40%
14K
100%
188K
1,242.86%
-61K
132.45%
-31K
49.18%
-167K
438.71%
-9K
94.61%
-91K
911.11%
-670K
636.26%
net income
-6.94M
-
-9.69M
39.63%
-11.45M
18.12%
-16.46M
43.84%
-18.49M
12.31%
-7.93M
57.11%
-5.48M
30.88%
-9.74M
77.64%
-19.23M
97.48%
-9.26M
51.87%
-5.34M
42.32%
weighted average shs out
68.49K
-
162.71K
137.57%
349.41K
114.74%
503.75K
44.17%
579.53K
15.04%
769.40K
32.76%
1.32M
71.72%
4.71M
256.50%
13.90M
195.18%
14.41M
3.64%
14.42B
99,939.79%
weighted average shs out dil
68.49K
-
162.71K
137.57%
349.41K
114.74%
503.75K
44.17%
579.53K
15.04%
769.40K
32.76%
1.32M
71.72%
4.71M
256.50%
13.90M
195.18%
14.41M
3.64%
14.42B
99,939.79%
eps
-101.32
-
-59.55
41.23%
-32.76
44.99%
-32.68
0.24%
-31.91
2.36%
-10.31
67.69%
-4.15
59.75%
-2.07
50.12%
-1.38
33.33%
-0.64
53.62%
-0.00
99.94%
epsdiluted
-101.32
-
-59.55
41.23%
-32.76
44.99%
-32.68
0.24%
-31.91
2.36%
-10.31
67.69%
-4.15
59.75%
-2.07
50.12%
-1.38
33.33%
-0.64
53.62%
-0.00
99.94%

All numbers in USD (except ratios and percentages)